<code id='E75E30819E'></code><style id='E75E30819E'></style>
    • <acronym id='E75E30819E'></acronym>
      <center id='E75E30819E'><center id='E75E30819E'><tfoot id='E75E30819E'></tfoot></center><abbr id='E75E30819E'><dir id='E75E30819E'><tfoot id='E75E30819E'></tfoot><noframes id='E75E30819E'>

    • <optgroup id='E75E30819E'><strike id='E75E30819E'><sup id='E75E30819E'></sup></strike><code id='E75E30819E'></code></optgroup>
        1. <b id='E75E30819E'><label id='E75E30819E'><select id='E75E30819E'><dt id='E75E30819E'><span id='E75E30819E'></span></dt></select></label></b><u id='E75E30819E'></u>
          <i id='E75E30819E'><strike id='E75E30819E'><tt id='E75E30819E'><pre id='E75E30819E'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:34776
          Adobe

          Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

          In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

          advertisement

          The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Kansas bar where gunfire wounded 9 last month closes permanently
          Kansas bar where gunfire wounded 9 last month closes permanently

          WICHITA,Kan.--TheKansasbarwhereninepeoplewerewoundedbygunfirelastmonthhaspermanentlyclosed.Anattorne

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Researchers use wearables data and AI to predict preterm birth risk

          AdobeForalltheirpotentialtodrivechangesinhealth,wearableshavestruggledtogainafootholdinmedicine.Thed